ADVFN Logo ADVFN

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,693.31
-0.33%
Dow Jones
42,299.70
-0.37%
US Dollar vs MXN
20.33635
0.19%
Brent Oil
73.305
-0.12%
Bitcoin
85,206.30
-2.30%
Pepperstone
Advertisement
Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Axogen Inc (AXGN)

  7. Axogen Inc (AXGN) Noticias

AXGN

Axogen (AXGN)

Axogen Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:AXGN
FechaHoraFuenteTítuloSímboloCompañía
26/03/202515:53Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AXGNAxogen Inc
24/03/202507:00GlobeNewswire Inc.Axogen Announces Appointment of Rick Ditto as Vice President, Global Health Economics, Reimbursement & Policy, and Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:AXGNAxogen Inc
05/03/202517:52Edgar (US Regulatory)Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]NASDAQ:AXGNAxogen Inc
04/03/202506:06Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:AXGNAxogen Inc
03/03/202515:16Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:AXGNAxogen Inc
26/02/202515:09Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:AXGNAxogen Inc
25/02/202506:10GlobeNewswire Inc.Axogen, Inc. To Host Analyst & Investor Day on March 4thNASDAQ:AXGNAxogen Inc
25/02/202506:00GlobeNewswire Inc.Axogen, Inc. Reports 2024 Fourth Quarter and Full-Year Financial ResultsNASDAQ:AXGNAxogen Inc
11/02/202515:58GlobeNewswire Inc.Axogen, Inc. to report 2024 fourth quarter and full year financial results on February 25, 2025NASDAQ:AXGNAxogen Inc
03/02/202514:33Edgar (US Regulatory)Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:AXGNAxogen Inc
03/02/202507:00GlobeNewswire Inc.Axogen Announces Appointment of Jesse Bishop as Vice President of Regulatory Affairs and Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:AXGNAxogen Inc
10/01/202516:00GlobeNewswire Inc.Axogen Announces New VP of Operations and Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:AXGNAxogen Inc
10/01/202507:00GlobeNewswire Inc.Axogen Reports Preliminary Unaudited Revenue for Fourth Quarter and Full-Year 2024NASDAQ:AXGNAxogen Inc
06/01/202517:40Edgar (US Regulatory)Form 5 - Annual statement of changes in beneficial ownership of securitiesNASDAQ:AXGNAxogen Inc
14/11/202414:31Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:AXGNAxogen Inc
07/11/202415:34Edgar (US Regulatory)Form SC 13G - Statement of Beneficial Ownership by Certain InvestorsNASDAQ:AXGNAxogen Inc
07/11/202415:12Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:AXGNAxogen Inc
07/11/202406:00GlobeNewswire Inc.Axogen, Inc Reports Third Quarter 2024 Financial Results and Provides BLA UpdateNASDAQ:AXGNAxogen Inc
24/10/202406:00GlobeNewswire Inc.Axogen, Inc. to report third quarter 2024 financial results and host conference call on November 7, 2024NASDAQ:AXGNAxogen Inc
06/09/202406:00GlobeNewswire Inc.Axogen Completes Submission of Biologics License Application to U.S. Food and Drug Administration for Avance Nerve Graft®NASDAQ:AXGNAxogen Inc
03/09/202406:00GlobeNewswire Inc.Axogen Reports Inducement Grant to New Employee Under NASDAQ Listing Rule 5635(C)(4)NASDAQ:AXGNAxogen Inc
13/08/202415:18GlobeNewswire Inc.CytoSorbents Appoints Peter J. Mariani Chief Financial OfficerNASDAQ:AXGNAxogen Inc
09/08/202415:36Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:AXGNAxogen Inc
09/08/202415:15Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:AXGNAxogen Inc
08/08/202406:05GlobeNewswire Inc.Axogen, Inc. Announces New Leadership AppointmentsNASDAQ:AXGNAxogen Inc
08/08/202406:00GlobeNewswire Inc.Axogen, Inc. Reports Second Quarter 2024 Financial ResultsNASDAQ:AXGNAxogen Inc
23/07/202406:00GlobeNewswire Inc.Axogen, Inc. to Report Second Quarter 2024 Financial Results and Host Conference Call on August 8, 2024NASDAQ:AXGNAxogen Inc
01/07/202406:00GlobeNewswire Inc.Company Reports Inducement Grants to Non-Executive New Employee Under Nasdaq Listing Rule 5635(C)(4)NASDAQ:AXGNAxogen Inc
24/06/202406:00GlobeNewswire Inc.Axogen, Inc Announces Full Launch of Avive+ Soft Tissue Matrix™NASDAQ:AXGNAxogen Inc
28/05/202415:30GlobeNewswire Inc.Axogen Processing Center (APC) Celebrates its Opening with Ohio Leaders in VandaliaNASDAQ:AXGNAxogen Inc
 Showing the most relevant articles for your search:NASDAQ:AXGN

Su Consulta Reciente

COIN
OMGUSD
OMG Network
Delayed Upgrade Clock
ADVFN Logo
México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2025 ADVFN PLC - Todos los derechos reservados

Quitar anuncios

Suscríbete a una experiencia sin publicidad

Sin anuncios

Pruébalo ahora

Mantenga los anuncios